Literature DB >> 25175816

Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer.

Masaki Ohashi1, Shinji Morita, Takeo Fukagawa, Ryoji Kushima, Hitoshi Katai.   

Abstract

BACKGROUND AND OBJECTIVES: The optimal surgical procedure for gastric remnant carcinoma (GRC) remains debatable. The aim of this study was to retrospectively evaluate the surgical treatments for T2-4 GRC developing after distal gastrectomy for gastric cancer.
METHODS: Between 1970 and 2012, a total of 50 patients underwent R0 resection for T2-4 GRC. The clinicopathologic features, therapeutic methods, and follow-up data of these patients were reviewed.
RESULTS: The tumor was located at a non-anastomotic site of the remnant stomach in 43 of the 50 patients. Total gastrectomy was performed in 48 patients and partial gastrectomy was in two patients. Lymph node metastasis was found in 19 patients. Major postoperative complications occurred in 16 patients. The overall 1-, 3-, and 5-year survival rates of the 50 patients were 90%, 66%, and 44%, respectively. Presence of small intestinal or esophageal infiltration and postoperative complications was independently associated with poorer survival. Dissection of the perigastric and splenic hilar/artery nodes was found to have potential therapeutic benefit.
CONCLUSIONS: Surgical resection for T2-4 GRC developing after distal gastrectomy for gastric cancer can be invasive, but is feasible and effective. Total gastrectomy with splenectomy is one of the recommendable procedures for this disease.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastrectomy; outcome; remnant gastric cancer; splenectomy; surgical treatment

Mesh:

Year:  2014        PMID: 25175816     DOI: 10.1002/jso.23774

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Gastric Remnant Cancer: Is it different From Primary Gastric Cancer? Insights Into a Unique Clinical Entity.

Authors:  Mashaal Dhir
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Effects of initial disease status on lymph flow following gastrectomy in cases of carcinoma in the remnant stomach.

Authors:  Shinsaku Honda; Etsuro Bando; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Taiichi Kawamura; Teiichi Sugiura; Yusuke Kinugasa; Katsuhiko Uesaka; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-09-16       Impact factor: 7.370

3.  Incidence of adhesive small bowel obstruction after gastrectomy for gastric cancer and its risk factors: a long-term retrospective cohort study from a high-volume institution in China.

Authors:  Tao Pan; Danil Galiullin; Xiao-Long Chen; Wei-Han Zhang; Kun Yang; Kai Liu; Lin-Yong Zhao; Xin-Zu Chen; Jian-Kun Hu
Journal:  Updates Surg       Date:  2021-02-06

4.  Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer.

Authors:  Kazuya Takahashi; Takaki Yoshikawa; Shinji Morita; Takahiro Kinoshita; Masahiro Yura; Sho Otsuki; Masanori Tokunaga; Yukinori Yamagata; Akio Kaito; Hitoshi Katai
Journal:  Gastric Cancer       Date:  2019-07-13       Impact factor: 7.370

5.  DNA methylation genome-wide analysis in remnant and primary gastric cancers.

Authors:  Kiichi Sugimoto; Tomoaki Ito; Alicia Hulbert; Chen Chen; Hajime Orita; Masahiro Maeda; Hiroshi Moro; Takeo Fukagawa; Toshikazu Ushijima; Hitoshi Katai; Ryo Wada; Koichi Sato; Kazuhiro Sakamoto; Wayne Yu; Michael Considine; Leslie Cope; Malcolm V Brock
Journal:  Gastric Cancer       Date:  2019-03-12       Impact factor: 7.370

6.  [Gastric stump carcinoma: frequency, treatment, complications and prognosis].

Authors:  H Nienhüser; S Blank; L Sisic; R Kunzmann; U Heger; K Ott; M W Büchler; T Schmidt; A Ulrich
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

Review 7.  Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Takeo Fukagawa; Yoshio Haga; Koji Oba
Journal:  Gastric Cancer       Date:  2015-12-14       Impact factor: 7.370

8.  Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible?

Authors:  Fu-Hai Ma; Hao Liu; Shuai Ma; Yang Li; Yan-Tao Tian
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

Review 9.  Disadvantages of Complete No. 10 Lymph Node Dissection in Gastric Cancer and the Possibility of Spleen-Preserving Dissection: Review.

Authors:  Tetsuro Toriumi; Masanori Terashima
Journal:  J Gastric Cancer       Date:  2020-02-27       Impact factor: 3.720

10.  Role of Postoperative Complications in Overall Survival after Radical Resection for Gastric Cancer: A Retrospective Single-Center Analysis of 1107 Patients.

Authors:  Christian Galata; Susanne Blank; Christel Weiss; Ulrich Ronellenfitsch; Christoph Reissfelder; Julia Hardt
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.